Patricia K. Welch - Concepedia

Author

Patricia K. Welch

Bristol-Myers Squibb (United States)

Also Known As

Patricia K Welch, Patricia K. Welch

Publications

307

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Experimental Station

About

Patricia K. Welch is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	184
2	Natural Sciences	3	3	89
3	Public Health	2	2	61
4	Health Sciences	1	1	37
5	Allergy	1	1	46

Patricia K. Welch

Publications

307

Citations

H-Index

Page 1

	Year	Citations
Discovery of CC Chemokine Receptor-3 (CCR3) Antagonists with Picomolar Potency George V. De Lucca, Ui Tae Kim, Brian J. Vargo, Journal of Medicinal Chemistry	2005	62
Discovery and Structure−Activity Relationship of N-(Ureidoalkyl)-Benzyl-Piperidines As Potent Small Molecule CC Chemokine Receptor-3 (CCR3) Antagonists George V. De Lucca, Ui T. Kim, Curt Johnson, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryDrug TargetBiochemistryFunctional Selectivity	2002	48
CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure–activity relationships Dean A. Wacker, Joseph B. Santella, Daniel S. Gardner, Bioorganic & Medicinal Chemistry Letters AsthmaCcr3 AntagonistsPotential New TherapyAnti-inflammatoryAllergy	2002	46
Nutrition Education, Body Composition, and Dietary Intake of Female College Athletes Patricia K. Welch, Kathleen A. Zager, Jeannette Endres, The Physician and Sportsmedicine NutritionPhysical ActivityPublic Health NutritionFemale AthletesObesity	1987	37
From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: The discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis Joseph B. Santella, Daniel S. Gardner, Wenqing Yao, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryAcyclic ScaffoldsMedicineNatural Sciences	2007	30
Position of the American Dietetic Association Becky Dorner, Kathleen C Niedert, Patricia K. Welch Journal of the American Dietetic Association NutritionDiet QualityAmerican Dietetic AssociationDieteticsPublic Health Nutrition	2002	24
N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists Douglas G. Batt, Gregory C. Houghton, John Roderick, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyFunctional SelectivityMedicineReceptor (Biochemistry)N-arylalkylpiperidine Urea Derivatives	2004	18
CC chemokine receptor-3 (CCR3) antagonists: Improving the selectivity of DPC168 by reducing central ring lipophilicity James R. Pruitt, Douglas G. Batt, Dean A. Wacker, Bioorganic & Medicinal Chemistry Letters InflammationCentral Ring LipophilicityBiochemistryCc Chemokine Receptor-3Medicine	2007	16
2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: Synthesis and selectivity Paul S. Watson, Bin Jiang, K.A. Harrison, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryFunctional SelectivityMedicinePharmacological AgentPharmacotherapy	2006	15
From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonists Daniel S. Gardner, Joseph B. Santella, Andrew J. Tebben, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryAcyclic ScaffoldsNatural SciencesMedicine	2007	11

Page 1